title: Complete pathologic response in soft tissue sarcoma lung metastases with pazopanib.
authors.affiliation: Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Eroglu
authors.forename: Jae
authors.initials: J
authors.lastname: Kim
authors.forename: Sharon
authors.initials: S
authors.lastname: Wilczynski
authors.forename: Warren A
authors.initials: WA
authors.lastname: Chow
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007191:Indazoles; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D013449:Sulfonamides / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D020533:Angiogenesis Inhibitors; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib